NCIt definition : An orally bioavailable inhibitor of the serine/threonine protein kinase Akt (protein
kinase B) with potential antineoplastic activity. Afuresertib binds to and inhibits
the activity of Akt, which may result in inhibition of the PI3K/Akt signaling pathway
and tumor cell proliferation and the induction of tumor cell apoptosis. Activation
of the PI3K/Akt signaling pathway is frequently associated with tumorigenesis and
dysregulated PI3K/Akt signaling may contribute to tumor resistance to a variety of
antineoplastic agents.;
UNII : 8739X25QI3;
InChIKey : AFJRDFWMXUECEW-LBPRGKRZSA-N;
CAS number : 1047644-62-1; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1047644-62-1
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;